top of page

GL09

Rethinking NTM management: new drugs, new approaches, new hope

N Lorent(1)

1: KU Leuven

Nontuberculous mycobacteria (NTM) present a growing clinical challenge due to their intrinsic resistance and the complexity of treatment regimens. This lecture will provide an overview of current therapeutic approaches to NTM infections, encompassing both antibiotic and non-antibiotic strategies. Emphasis will be placed on emerging compounds under investigation and the latest evidence guiding their potential use. Ongoing clinical trials and research gaps will also be highlighted, offering insights into future directions for NTM management.

ESM Logo_White.png

Registered address:
c/o TREASURER
Matthias Merker
Parkallee 1
23845 Borstel
Germany

  • Facebook
  • LinkedIn
  • YouTube

© 2021 The European Society of Mycobacteriology

bottom of page